Ophthalmology Times

Glaukos’ Epioxa for keratoconus receives permanent J-code effective July 1, 2026

Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...
Investing.com

Glaukos erhält permanenten J-Code für Keratokonus-Behandlung Epioxa

ALISO VIEJO, Kalifornien – Die Glaukos Corporation (NYSE:GKOS) gab die Zuteilung eines permanenten J-Codes des Healthcare Common Procedure Coding System für ihre Keratokonus-Behandlung Epioxa durch ...
Investing

Glaukos receives new J-code for keratoconus treatment Epioxa

ALISO VIEJO, Calif. - Glaukos Corporation (NYSE:GKOS) announced the U.S. Centers for Medicare and Medicaid Services has assigned a permanent Healthcare Common Procedure Coding System J-code for Epioxa ...
C&EN

Bifunctional Iminophosphorane Catalyzed Enantioselective Sulfa-Michael Addition to Unactivated α-Substituted Acrylate Esters

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only ...
C&EN

Organometallic Folate Gold Nanoparticles Ameliorate Lipopolysaccharide-Induced Oxidative Damage and Inflammation in Zebrafish Brain

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...